Loading…

Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study

AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspect...

Full description

Saved in:
Bibliographic Details
Published in:BMJ (Online) 2019-10, Vol.367, p.l5894-l5894
Main Authors: Becerra, Mercedes C, Huang, Chuan-Chin, Lecca, Leonid, Bayona, Jaime, Contreras, Carmen, Calderon, Roger, Yataco, Rosa, Galea, Jerome, Zhang, Zibiao, Atwood, Sidney, Cohen, Ted, Mitnick, Carole D, Farmer, Paul, Murray, Megan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3
cites cdi_FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3
container_end_page l5894
container_issue
container_start_page l5894
container_title BMJ (Online)
container_volume 367
creator Becerra, Mercedes C
Huang, Chuan-Chin
Lecca, Leonid
Bayona, Jaime
Contreras, Carmen
Calderon, Roger
Yataco, Rosa
Galea, Jerome
Zhang, Zibiao
Atwood, Sidney
Cohen, Ted
Mitnick, Carole D
Farmer, Paul
Murray, Megan
description AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspective cohort study.Participants10 160 household contacts of 3339 index patients with tuberculosis were classified on the basis of the drug resistance profile of the patient: 6189 were exposed to drug susceptible strains of Mycobacterium tuberculosis, 1659 to strains resistant to isoniazid or rifampicin, and 1541 to strains that were multidrug resistant (resistant to isoniazid and rifampicin).Main outcome measuresTuberculosis infection (positive tuberculin skin test) and the incidence of active disease (diagnosed by positive sputum smear or chest radiograph) after 12 months of follow-up.ResultsHousehold contacts exposed to patients with multidrug resistant tuberculosis had an 8% (95% confidence interval 4% to 13%) higher risk of infection by the end of follow-up compared with household contacts of patients with drug sensitive tuberculosis. The relative hazard of incident tuberculosis disease did not differ among household contacts exposed to multidrug resistant tuberculosis and those exposed to drug sensitive tuberculosis (adjusted hazard ratio 1.28, 95% confidence interval 0.9 to 1.83).ConclusionHousehold contacts of patients with multidrug resistant tuberculosis were at higher risk of tuberculosis infection than contacts exposed to drug sensitive tuberculosis. The risk of developing tuberculosis disease did not differ among contacts in both groups. The evidence invites guideline producers to take action by targeting drug resistant and drug sensitive tuberculosis, such as early detection and effective treatment of infection and disease.Trial registrationClinicalTrials.gov NCT00676754.
doi_str_mv 10.1136/bmj.l5894
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6812583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2309470953</sourcerecordid><originalsourceid>FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3</originalsourceid><addsrcrecordid>eNp1kU1rHDEMhk1paJZNDv0HhvbQHia11x_j6aEQQpMWEnJJz0b2eDZeZsZTfwT20P9ebzYUWuhJSHokpPdF6C0lF5Qy-clMu4tRqI6_QivaCtlQxdhrtCKd6BpFmTpF5yntCCEb1qpOijfolFHJO0LbFfr1EGFOk0_JGz_6vMcw93gJ2c3Zw4iHEHHvk4Pk8BLDNrpKhhmHAfexbHHNfcowZ3y3t8GAzS76MuFcjIu2jKG2Px8m0-Js9k8O2_AYYsYpl35_hk4GGJM7f4lr9OP668PVt-b2_ub71eVtY1jLcwNtaxhh1jmurGVEGKADZYYA8MGSlgg59HJg0EtFgDOz4V2dcJIrCaK3bI2-HPcuxUyut_W5CKNeop8g7nUAr__uzP5Rb8OTlopuRNVzjT68LIjhZ3Ep6yqZdeMIswsl6Q0jHW-r5Af03T_oLpQ41_eeqepKR0SlPh4pW6VJ0Q1_jqFEH3zV1Vf97Gtl3x_ZQ-n_2G9PsaUQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2309959905</pqid></control><display><type>article</type><title>Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>BMJ Journals</source><creator>Becerra, Mercedes C ; Huang, Chuan-Chin ; Lecca, Leonid ; Bayona, Jaime ; Contreras, Carmen ; Calderon, Roger ; Yataco, Rosa ; Galea, Jerome ; Zhang, Zibiao ; Atwood, Sidney ; Cohen, Ted ; Mitnick, Carole D ; Farmer, Paul ; Murray, Megan</creator><creatorcontrib>Becerra, Mercedes C ; Huang, Chuan-Chin ; Lecca, Leonid ; Bayona, Jaime ; Contreras, Carmen ; Calderon, Roger ; Yataco, Rosa ; Galea, Jerome ; Zhang, Zibiao ; Atwood, Sidney ; Cohen, Ted ; Mitnick, Carole D ; Farmer, Paul ; Murray, Megan</creatorcontrib><description>AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspective cohort study.Participants10 160 household contacts of 3339 index patients with tuberculosis were classified on the basis of the drug resistance profile of the patient: 6189 were exposed to drug susceptible strains of Mycobacterium tuberculosis, 1659 to strains resistant to isoniazid or rifampicin, and 1541 to strains that were multidrug resistant (resistant to isoniazid and rifampicin).Main outcome measuresTuberculosis infection (positive tuberculin skin test) and the incidence of active disease (diagnosed by positive sputum smear or chest radiograph) after 12 months of follow-up.ResultsHousehold contacts exposed to patients with multidrug resistant tuberculosis had an 8% (95% confidence interval 4% to 13%) higher risk of infection by the end of follow-up compared with household contacts of patients with drug sensitive tuberculosis. The relative hazard of incident tuberculosis disease did not differ among household contacts exposed to multidrug resistant tuberculosis and those exposed to drug sensitive tuberculosis (adjusted hazard ratio 1.28, 95% confidence interval 0.9 to 1.83).ConclusionHousehold contacts of patients with multidrug resistant tuberculosis were at higher risk of tuberculosis infection than contacts exposed to drug sensitive tuberculosis. The risk of developing tuberculosis disease did not differ among contacts in both groups. The evidence invites guideline producers to take action by targeting drug resistant and drug sensitive tuberculosis, such as early detection and effective treatment of infection and disease.Trial registrationClinicalTrials.gov NCT00676754.</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.l5894</identifier><identifier>PMID: 31649017</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Cohort analysis ; Drug resistance ; Epidemiology ; Households ; Isoniazid ; Multidrug resistance ; Mycobacterium tuberculosis ; Rifampin ; Skin tests ; Sputum ; Tuberculin ; Tuberculosis</subject><ispartof>BMJ (Online), 2019-10, Vol.367, p.l5894-l5894</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2019 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2019 BMJ</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3</citedby><cites>FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3</cites><orcidid>0000-0003-0443-1986</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://bmj.com/content/367/bmj.l5894.full.pdf$$EPDF$$P50$$Gbmj$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://bmj.com/content/367/bmj.l5894.full$$EHTML$$P50$$Gbmj$$Hfree_for_read</linktohtml><link.rule.ids>112,113,230,314,780,784,885,3194,27924,27925,77594,77595</link.rule.ids></links><search><creatorcontrib>Becerra, Mercedes C</creatorcontrib><creatorcontrib>Huang, Chuan-Chin</creatorcontrib><creatorcontrib>Lecca, Leonid</creatorcontrib><creatorcontrib>Bayona, Jaime</creatorcontrib><creatorcontrib>Contreras, Carmen</creatorcontrib><creatorcontrib>Calderon, Roger</creatorcontrib><creatorcontrib>Yataco, Rosa</creatorcontrib><creatorcontrib>Galea, Jerome</creatorcontrib><creatorcontrib>Zhang, Zibiao</creatorcontrib><creatorcontrib>Atwood, Sidney</creatorcontrib><creatorcontrib>Cohen, Ted</creatorcontrib><creatorcontrib>Mitnick, Carole D</creatorcontrib><creatorcontrib>Farmer, Paul</creatorcontrib><creatorcontrib>Murray, Megan</creatorcontrib><title>Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study</title><title>BMJ (Online)</title><description>AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspective cohort study.Participants10 160 household contacts of 3339 index patients with tuberculosis were classified on the basis of the drug resistance profile of the patient: 6189 were exposed to drug susceptible strains of Mycobacterium tuberculosis, 1659 to strains resistant to isoniazid or rifampicin, and 1541 to strains that were multidrug resistant (resistant to isoniazid and rifampicin).Main outcome measuresTuberculosis infection (positive tuberculin skin test) and the incidence of active disease (diagnosed by positive sputum smear or chest radiograph) after 12 months of follow-up.ResultsHousehold contacts exposed to patients with multidrug resistant tuberculosis had an 8% (95% confidence interval 4% to 13%) higher risk of infection by the end of follow-up compared with household contacts of patients with drug sensitive tuberculosis. The relative hazard of incident tuberculosis disease did not differ among household contacts exposed to multidrug resistant tuberculosis and those exposed to drug sensitive tuberculosis (adjusted hazard ratio 1.28, 95% confidence interval 0.9 to 1.83).ConclusionHousehold contacts of patients with multidrug resistant tuberculosis were at higher risk of tuberculosis infection than contacts exposed to drug sensitive tuberculosis. The risk of developing tuberculosis disease did not differ among contacts in both groups. The evidence invites guideline producers to take action by targeting drug resistant and drug sensitive tuberculosis, such as early detection and effective treatment of infection and disease.Trial registrationClinicalTrials.gov NCT00676754.</description><subject>Cohort analysis</subject><subject>Drug resistance</subject><subject>Epidemiology</subject><subject>Households</subject><subject>Isoniazid</subject><subject>Multidrug resistance</subject><subject>Mycobacterium tuberculosis</subject><subject>Rifampin</subject><subject>Skin tests</subject><subject>Sputum</subject><subject>Tuberculin</subject><subject>Tuberculosis</subject><issn>0959-8138</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><recordid>eNp1kU1rHDEMhk1paJZNDv0HhvbQHia11x_j6aEQQpMWEnJJz0b2eDZeZsZTfwT20P9ebzYUWuhJSHokpPdF6C0lF5Qy-clMu4tRqI6_QivaCtlQxdhrtCKd6BpFmTpF5yntCCEb1qpOijfolFHJO0LbFfr1EGFOk0_JGz_6vMcw93gJ2c3Zw4iHEHHvk4Pk8BLDNrpKhhmHAfexbHHNfcowZ3y3t8GAzS76MuFcjIu2jKG2Px8m0-Js9k8O2_AYYsYpl35_hk4GGJM7f4lr9OP668PVt-b2_ub71eVtY1jLcwNtaxhh1jmurGVEGKADZYYA8MGSlgg59HJg0EtFgDOz4V2dcJIrCaK3bI2-HPcuxUyut_W5CKNeop8g7nUAr__uzP5Rb8OTlopuRNVzjT68LIjhZ3Ep6yqZdeMIswsl6Q0jHW-r5Af03T_oLpQ41_eeqepKR0SlPh4pW6VJ0Q1_jqFEH3zV1Vf97Gtl3x_ZQ-n_2G9PsaUQ</recordid><startdate>20191024</startdate><enddate>20191024</enddate><creator>Becerra, Mercedes C</creator><creator>Huang, Chuan-Chin</creator><creator>Lecca, Leonid</creator><creator>Bayona, Jaime</creator><creator>Contreras, Carmen</creator><creator>Calderon, Roger</creator><creator>Yataco, Rosa</creator><creator>Galea, Jerome</creator><creator>Zhang, Zibiao</creator><creator>Atwood, Sidney</creator><creator>Cohen, Ted</creator><creator>Mitnick, Carole D</creator><creator>Farmer, Paul</creator><creator>Murray, Megan</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group Ltd</general><scope>9YT</scope><scope>ACMMV</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0443-1986</orcidid></search><sort><creationdate>20191024</creationdate><title>Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study</title><author>Becerra, Mercedes C ; Huang, Chuan-Chin ; Lecca, Leonid ; Bayona, Jaime ; Contreras, Carmen ; Calderon, Roger ; Yataco, Rosa ; Galea, Jerome ; Zhang, Zibiao ; Atwood, Sidney ; Cohen, Ted ; Mitnick, Carole D ; Farmer, Paul ; Murray, Megan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Cohort analysis</topic><topic>Drug resistance</topic><topic>Epidemiology</topic><topic>Households</topic><topic>Isoniazid</topic><topic>Multidrug resistance</topic><topic>Mycobacterium tuberculosis</topic><topic>Rifampin</topic><topic>Skin tests</topic><topic>Sputum</topic><topic>Tuberculin</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Becerra, Mercedes C</creatorcontrib><creatorcontrib>Huang, Chuan-Chin</creatorcontrib><creatorcontrib>Lecca, Leonid</creatorcontrib><creatorcontrib>Bayona, Jaime</creatorcontrib><creatorcontrib>Contreras, Carmen</creatorcontrib><creatorcontrib>Calderon, Roger</creatorcontrib><creatorcontrib>Yataco, Rosa</creatorcontrib><creatorcontrib>Galea, Jerome</creatorcontrib><creatorcontrib>Zhang, Zibiao</creatorcontrib><creatorcontrib>Atwood, Sidney</creatorcontrib><creatorcontrib>Cohen, Ted</creatorcontrib><creatorcontrib>Mitnick, Carole D</creatorcontrib><creatorcontrib>Farmer, Paul</creatorcontrib><creatorcontrib>Murray, Megan</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest research library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Becerra, Mercedes C</au><au>Huang, Chuan-Chin</au><au>Lecca, Leonid</au><au>Bayona, Jaime</au><au>Contreras, Carmen</au><au>Calderon, Roger</au><au>Yataco, Rosa</au><au>Galea, Jerome</au><au>Zhang, Zibiao</au><au>Atwood, Sidney</au><au>Cohen, Ted</au><au>Mitnick, Carole D</au><au>Farmer, Paul</au><au>Murray, Megan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study</atitle><jtitle>BMJ (Online)</jtitle><date>2019-10-24</date><risdate>2019</risdate><volume>367</volume><spage>l5894</spage><epage>l5894</epage><pages>l5894-l5894</pages><issn>0959-8138</issn><eissn>1756-1833</eissn><abstract>AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspective cohort study.Participants10 160 household contacts of 3339 index patients with tuberculosis were classified on the basis of the drug resistance profile of the patient: 6189 were exposed to drug susceptible strains of Mycobacterium tuberculosis, 1659 to strains resistant to isoniazid or rifampicin, and 1541 to strains that were multidrug resistant (resistant to isoniazid and rifampicin).Main outcome measuresTuberculosis infection (positive tuberculin skin test) and the incidence of active disease (diagnosed by positive sputum smear or chest radiograph) after 12 months of follow-up.ResultsHousehold contacts exposed to patients with multidrug resistant tuberculosis had an 8% (95% confidence interval 4% to 13%) higher risk of infection by the end of follow-up compared with household contacts of patients with drug sensitive tuberculosis. The relative hazard of incident tuberculosis disease did not differ among household contacts exposed to multidrug resistant tuberculosis and those exposed to drug sensitive tuberculosis (adjusted hazard ratio 1.28, 95% confidence interval 0.9 to 1.83).ConclusionHousehold contacts of patients with multidrug resistant tuberculosis were at higher risk of tuberculosis infection than contacts exposed to drug sensitive tuberculosis. The risk of developing tuberculosis disease did not differ among contacts in both groups. The evidence invites guideline producers to take action by targeting drug resistant and drug sensitive tuberculosis, such as early detection and effective treatment of infection and disease.Trial registrationClinicalTrials.gov NCT00676754.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><pmid>31649017</pmid><doi>10.1136/bmj.l5894</doi><orcidid>https://orcid.org/0000-0003-0443-1986</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-8138
ispartof BMJ (Online), 2019-10, Vol.367, p.l5894-l5894
issn 0959-8138
1756-1833
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6812583
source JSTOR Archival Journals and Primary Sources Collection; BMJ Journals
subjects Cohort analysis
Drug resistance
Epidemiology
Households
Isoniazid
Multidrug resistance
Mycobacterium tuberculosis
Rifampin
Skin tests
Sputum
Tuberculin
Tuberculosis
title Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A16%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transmissibility%20and%20potential%20for%20disease%20progression%20of%20drug%20resistant%20Mycobacterium%20tuberculosis:%20prospective%20cohort%20study&rft.jtitle=BMJ%20(Online)&rft.au=Becerra,%20Mercedes%20C&rft.date=2019-10-24&rft.volume=367&rft.spage=l5894&rft.epage=l5894&rft.pages=l5894-l5894&rft.issn=0959-8138&rft.eissn=1756-1833&rft_id=info:doi/10.1136/bmj.l5894&rft_dat=%3Cproquest_pubme%3E2309470953%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2309959905&rft_id=info:pmid/31649017&rfr_iscdi=true